4.4 Article

SARS-CoV-2 acute bronchiolitis in hospitalized children: Neither frequent nor more severe

Journal

PEDIATRIC PULMONOLOGY
Volume 57, Issue 1, Pages 57-65

Publisher

WILEY
DOI: 10.1002/ppul.25731

Keywords

bronchiolitis; coronavirus; infants; pandemic

Funding

  1. Instituto de Salud Carlos III (Ministry of Economy, Industry and Competitiveness)
  2. European Regional Development Fund [PI20/00095]

Ask authors/readers for more resources

A study in Spain investigated children hospitalized with COVID-19 from March 1, 2020 to February 28, 2021, and found that 12 out of 666 children infected with SARS-CoV-2 developed bronchiolitis. The main symptoms included cough, rhinorrhea, difficulty breathing, and fever.
Introduction Endemic coronaviruses have been found in acute bronchiolitis, mainly as a coinfecting virus. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for respiratory illness in hospitalized children. The characteristics of patients with bronchiolitis have not been extensively described. Methods Cross-sectional study of patients with bronchiolitis and SARS-CoV-2 infection enrolled in a prospective multicenter cohort of children hospitalized with COVID-19 in Spain from March 1, 2020 to February 28, 2021. Results Twelve of 666 children infected with SARS-CoV-2 who required hospital admission met the diagnostic criteria for bronchiolitis (1.8%). Median age was 1.9 months (range: 0.4-10.1). Six cases had household contact with a confirmed or probable COVID-19 case. Main complaints were cough (11 patients), rhinorrhea (10), difficulty breathing (8), and fever (8). Eleven cases were classified as mild or moderate and one as severe. Laboratory tests performed in seven patients did not evidence anemia, lymphopenia, or high C-reactive protein levels. Chest X-rays were performed in six children, and one case showed remarkable findings. Coinfection with metapneumovirus was detected in the patient with the most severe course; Bordetella pertussis was detected in another patient. Seven patients required oxygen therapy. Albuterol was administered in four patients. One patient was admitted to the pediatric intensive care unit. Median length of admission was 4 days (range: 3-14). No patient died or showed any sequelae at discharge. Two patients developed recurrent bronchospasms. Conclusion SARS-CoV-2 infection does not seem to be a main trigger of severe bronchiolitis, and children with this condition should be managed according to clinical practice guidelines.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available